Actively Recruiting
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-06-13
380
Participants Needed
1
Research Sites
21 weeks
Total Duration
C
Centre Hospitalier Universitaire, Amiens
Lead Sponsor
C
Centre Hospitalier Universitaire Dijon
Collaborating Sponsor
Researchers are evaluating the use of veno-venous extracorporeal membrane oxygenation (VV-ECMO) in patients undergoing emergency thoracic surgery. This observational study aims to understand clinical outcomes and identify factors that affect prognosis in this high-risk group by comparing them to patients who received VV-ECMO for medical respiratory failure. Data is collected from two French academic centers, focusing on 90-day mortality and complications. The study compares two groups: patients receiving VV-ECMO during or after emergency thoracic surgery and those receiving VV-ECMO for medical respiratory failure. It is a retrospective, multicenter study that collects clinical data to assess differences in outcomes between these groups, including mortality and postoperative complications. The study does not involve experimental treatments but analyzes existing medical records. Participants will have their clinical data reviewed, including 90-day all-cause mortality and rates of complications following surgery. Researchers will study differences in mortality between oncologic and non-oncologic thoracic surgeries. The study spans from June 2025 to April 2026, focusing on gathering and analyzing retrospective data without requiring active treatment or intervention from participants during this period.
CONDITIONS
Prognosis of Veno-Venous Extracorporeal Membrane Oxygenation in Emergency Thoracic Surgery
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 90 days
Participants who undergo emergency thoracic surgery and VV-ECMO are observed for outcomes including mortality and complications.
Regular assessments during hospital stay and follow-up visits up to 90 days
Total: 1 location
1
CHRU Amiens
Amiens, France, 80480
Actively Recruiting
C
Christophe Beyls, MD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Christophe Beyls, Quintana Soulier-Zaninka, Olivier Georges...
https://pubmed.ncbi.nlm.nih.gov/41134639